Jubilant Life Sciences gains as its arm expands drug discovery alliance with Janssen

21 Feb 2014 Evaluate

Jubilant Life Sciences is currently trading at Rs. 112.30, up by 0.85 points or 0.76 % from its previous closing of Rs. 111.45 on the BSE.

The scrip opened at Rs. 112.80 and has touched a high and low of Rs. 112.80 and Rs. 112.30 respectively.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 210.00 on 22-Feb-2013 and a 52 week low of Rs. 65.10 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs. 128.65 and Rs. 111.00 respectively. The current market cap of the company is Rs. 1775.19 crore.

The promoters holding in the company stood at 53.95 % while Institutions and Non-Institutions held 26.50 % and 19.55 % respectively.

Jubilant Biosys, a Bengaluru based subsidiary of Jubilant Life Sciences, has expanded its drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium. The alliance was forged initially in the year 2011 and aims to deliver preclinical candidates to Janssen. The new agreement into multiple therapeutic areas has been expanded owing to Jubilant’s diversified skill sets in various therapeutic areas. Most of the research will be undertaken at Jubilant Biosys, India and some parts at Jubilant Discovery Center, USA.

Janssen Pharmaceutica, Belgium is part of the ‘Janssen Pharmaceutical Companies of Johnson & Johnson’. The collaboration between the two organizations has been expanded to leverage Jubilant’s drug discovery capabilities on selected drug discovery targets to advance programs in multiple disease areas. Jubilant will carry out research services and will deliver preclinical candidates to Janssen for potential development and commercialization. In addition to research funding, Jubilant will also receive milestones and royalties should Janssen successfully progress the assets into clinical development and commercialization.

Jubilant Life Sciences is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

 

Jubilant Pharmova Share Price

1068.20 18.80 (1.79%)
30-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.80
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 902.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×